![]()
Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | MIR1260B | Human | 17beta-estradiol | multiple interactions | EXP | | 6480464 | [Estradiol co-treated with Progesterone] results in decreased expression of MIR1260B mRNA | CTD | PMID:30328349 | MIR1260B | Human | 17beta-estradiol | decreases expression | EXP | | 6480464 | Estradiol results in decreased expression of MIR1260B mRNA | CTD | PMID:30328349 | MIR1260B | Human | chenodeoxycholic acid | increases expression | EXP | | 6480464 | Chenodeoxycholic Acid results in increased expression of MIR1260B mRNA | CTD | PMID:27174168 | MIR1260B | Human | cisplatin | multiple interactions | EXP | | 6480464 | [Cisplatin co-treated with jinfukang] results in decreased expression of MIR1260B mRNA | CTD | PMID:27392435 | MIR1260B | Human | hydroquinone | decreases expression | EXP | | 6480464 | hydroquinone results in decreased expression of MIR1260B mRNA | CTD | PMID:28733890 | MIR1260B | Human | Licochalcone B | decreases expression | EXP | | 6480464 | licochalcone B results in decreased expression of MIR1260B mRNA | CTD | PMID:33647349 | MIR1260B | Human | paracetamol | decreases expression | EXP | | 6480464 | Acetaminophen results in decreased expression of MIR1260B mRNA | CTD | PMID:28545106 | MIR1260B | Human | progesterone | multiple interactions | EXP | | 6480464 | [Estradiol co-treated with Progesterone] results in decreased expression of MIR1260B mRNA | CTD | PMID:30328349 | MIR1260B | Human | valproic acid | decreases expression | EXP | | 6480464 | Valproic Acid results in decreased expression of MIR1260B mRNA | CTD | PMID:29154799 | |